×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 2 Track 1: All Aboard the Globalization Train
Session Chair(s)
Taleen Kalebjian, PharmD
Senior Manager, Medical Information
Gilead Sciences, Inc., United States
The trend towards medical information globalization is clear, but the path and final product can look different for each organization. The results from a survey of several biopharmaceutical companies show us why companies decide to globalize, how they approach this process, and key components to a successful shift towards a global medical information department. We will then see some of these key learnings in action as one company shares their globalization journey.
Learning Objective : - Describe current trends in medical information globalization in areas including infrastructure, aspects of department globalization, and the use of technology
- Compare various models of globalization
- Discuss the value of globalization in regards to the company, the department, and the patient
- Recognize key challenges associated with globalization and best practices for overcoming them
Speaker(s)
PhactMI Benchmark Study Results
Mary K. Sendi, PharmD
Pfizer Inc, United States
MI Regional Lead North America
MI Globalization – Partnering with Affiliates
Ghiesla Nel
IPSEN PHARMA, France
Head of Global Medical Information